Latest News about NBIX
Recent news which mentions NBIX
   Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
   
  
  
  October 11, 2022
  From Benzinga
 
   3 Top Biotech Stocks Defying the Bear Market
   
  
  
  October 11, 2022
  From Motley Fool
 
   4 Analysts Have This to Say About Neurocrine Biosciences
   
  September 26, 2022
  Tickers 
   NBIX
  
  
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022
   
  
  
  September 26, 2022
  From Benzinga
 
   3 Growth Stocks That Are Crushing It This Year
   
  
  
  September 10, 2022
  From Motley Fool
 
   Neurocrine Biosciences Buys UK-Based Hormone Therapy Player
   
  August 30, 2022
  Tickers 
   NBIX
  
  
  From Benzinga
 
   Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
   
  
  
  August 05, 2022
  From Benzinga
 
   Neurocrine Biosciences (NBIX) Q2 2022 Earnings Call Transcript
   
  August 05, 2022
  Tickers 
   NBIX
  
  
  From Motley Fool
 From Benzinga
 From Benzinga
 From Benzinga
 Tickers 
   NBIX
  
  
  From Motley Fool
 
   Neurocrine Biosciences Q1 2022 Earnings Conference Call On May 4, 2022 At 08:00 AM ET
   
  April 25, 2022
  Tickers 
   NBIX
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2022
   
  
  
  February 25, 2022
  From Benzinga
 
   Looking Into Neurocrine Biosciences's Return On Capital Employed
   
  February 14, 2022
  Tickers 
   NBIX
  
  
  From Benzinga
 
   Neurocrine Biosciences (NBIX) Q4 2021 Earnings Call Transcript
   
  February 11, 2022
  Tickers 
   NBIX
  
  
  From Motley Fool
 
   The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
   
  
  
  February 11, 2022
  From Benzinga
 
   Earnings Scheduled For February 11, 2022
   
  
  
  February 11, 2022
  From Benzinga
 
   The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
   
  
  
  February 06, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.